Surgical robotics is changing the landscape in healthcare. Stereotaxis is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic.

David Fischel, the St. Louis, MO-based company’s chairman and CEO, is featured in this episode of Let’s Talk Medtech to discuss Stereotaxis’ journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA.

Fischel talks about the company’s game plan and his thoughts on the future of surgical robotics.